ESC Premium Access

Target populations and treatment cost for bempedoic acid and PCSK9 inhibitors: a simulation study in a contemporary CAD cohort

Congress Presentation

About the speaker

Doctor Christopher Blaum

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)
1 presentation
0 follower

4 more presentations in this session

Impact of ACLY on type 2 diabetes in UK Biobank: A Mendelian randomisation study

Speaker: Doctor A. Stiby (Oxford, GB)


Lipid testing trends before and after hospitalization for myocardial infarction among adults in the U.S., 2008-2019

Speaker: Ms C. Wiener (Durham, US)


The prevalence of statin intolerance worldwide: a systematic review and meta-analysis with 4,143,517 patients

Speaker: Doctor I. Bytyci (Pristina, XK)


Acute arterial events across all vascular territories in the FOURIER trial

Speaker: Doctor K. Oyama (Sendai, JP)


Access the full session

Highlights from the Young on cutting edge therapy for lowering lipids

Speakers: Doctor C. Blaum, Doctor A. Stiby, Ms C. Wiener, Doctor I. Bytyci, Doctor K. Oyama

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb